A protein sequence associated with Huntington’s disease may become life-saving vaccine component
(Cure Lab, Inc.) Protective or therapeutic vaccines have to be supplemented with adjuvants, strong facilitators of the immune response. A paper published today in the journal Vaccine by the Massachusetts based biotech company Cure Lab, Inc., describes a novel intra-molecular adjuvant. This adjuvant is a "protein tail" important in neurodegenerative Huntington's disease, that allows antigenic proteins to self-assemble into nano-size particles that safely activate both branches of the immune system.
In the arena that night, the whole last minute was drowned out by cheers — and then when the soaring music swelled, the confetti rained down as the harbinger of balloons and the hopeful first family took the stage, forget about it — it was a perfect end to a convention that last Monday, no one even knew if it would happen. But it did, and I'm so glad to have been there.
AP - Flanked by officials from the NAACP and the Southern Poverty Law Center, FBI Director Robert Mueller last year announced with considerable fanfare a new partnership between his agency and civil rights organizations.
